Hainan Huluwa Pharmaceutical Group Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 813.140 million compared to CNY 868.677 million a year ago. Operating income was CNY 93.527 million compared to CNY 61.252 million a year ago. Net income was CNY 75.074 million compared to CNY 47.350 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.13 a year ago.